Blog Post
Global Health Watch News Brief: Issue 1
The last week has brought an alarming series of developments affecting global health and human rights. Here’s a brief overview of critical changes and their implications.
Discover perspectives on the latest findings, biggest challenges and most exciting successes in our collective work.
At P-Values, you’ll find updates, perspective, insights and information from staff and partners working on the frontlines of research, advocacy and implementation. P-value is a statistical term for the probability that a trial result is reliable and not the outcome of chance.
Blog Post
The last week has brought an alarming series of developments affecting global health and human rights. Here’s a brief overview of critical changes and their implications.
Blog Post
The last week has been intense and sobering. As strategic and dedicated advocates, we already know the profound impact elections have on our work and our world. Recent developments in the United States underscore the challenges ahead, especially with the new administration’s alignment with the Project 2025 agenda—a playbook designed to reshape US federal agencies and policies drastically.
Blog Post
Among the first actions of the new US Presidential administration, was the announcement of the intent to formally withdraw the US from the WHO, which jeopardizes global health collaborations, data sharing, and inhibits WHO’s ability to address global health emergencies.
showing 1-10 of 1059
The last week has brought an alarming series of developments affecting global health and human rights. Here’s a brief overview of critical changes and their implications.
Prevention Option:
The last week has been intense and sobering. As strategic and dedicated advocates, we already know the profound impact elections have on our work and our world. Recent developments in the United States underscore the challenges ahead, especially with the new administration’s alignment with the Project 2025 agenda—a playbook designed to reshape US federal agencies and policies drastically.
Prevention Option:
Among the first actions of the new US Presidential administration, was the announcement of the intent to formally withdraw the US from the WHO, which jeopardizes global health collaborations, data sharing, and inhibits WHO’s ability to address global health emergencies.
Advocacy for HIV prevention and global health equity must heed MLK’s call — today and always. This series of AVAC’s advocates’ guides shares essential tools to advance HIV prevention and sexual and reproductive health as part of a comprehensive and integrated pathway to global health equity in 2025 and beyond.
Welcome to January 2025! This update shares new resources to keep you informed and inspired in the fight for choice, science, equity and sustainability in the HIV response in 2025 and beyond.
As we enter a new year, we also enter the midway point of the AVAC 2024-2025 Fellowship program, which runs 18 months. Fellows and their projects are taking giant strides in new areas of advocacy, and realizing strategic wins toward epidemic-bending goals, with much more to come!
Lenacapavir isn’t just another medication; it could be a catalyst for transformation. Together, we can seize this pivotal moment to revolutionize HIV prevention, paving the way for a future where innovative tools like lenacapavir reach everyone who needs them.
AVAC’s PxPulse podcast is back with its final episode of the year! This episode features Atuswege Mwangomale of Sikika, a COMPASS Africa partner. Listeners get a behind the scenes look at Sikika’s advocacy strategy around the successful passage of Tanzania’s Universal Health Insurance Bill, making health insurance mandatory for all citizens.
One year ago, AVAC published the Good Participatory Practice (GPP) Body of Evidence, an online clearinghouse of tools, best practices and analyses showcasing the power of GPP. Here, we bring you a report from the year since – how this clearinghouse of resources continues to demonstrate the value of GPP, and concrete examples from 2024 of GPP’s impact on major research agendas and mechanisms.
Prevention Option:
Topic:
This World AIDS Day, the HIV/AIDS response stands at a crossroads, with injectable lenacapavir set to transform HIV prevention. But as the new UNAIDS report highlights, it also comes at the same time as restrictive policies, economic instability, and geopolitical challenges threaten to frustrate access and rollback so much of the progress that has been achieved over the past two decades.
Prevention Option:
showing 1-10 of 1059
Discover perspectives on the latest findings, biggest challenges and most exciting successes in our collective work.
AVAC’s email list for organization and individuals interested in timely updates and critical perspectives on developments in biomedical HIV prevention.
A comprehensive round-up of HIV prevention media coverage and scientific publications.
Each month this podcast uses interviews, discussion and first-person reflections to explore vital topics confronting the field of HIV prevention research.
PxWire is AVAC’s quarterly update on biomedical HIV prevention. Each issue highlights key developments, challenges and opportunities, and features a centerspread infographic that provides a visual tool for framing these issues.
Pandemic Watch is a curated news digest on the latest pandemic prevention, preparedness, and response (PPPR) news and resources.
A collection of official statements from AVAC.
Media clippings featuring AVAC, its staff and close partners in the news media.